[1]
S. Galdy, “Oxaliplatin-based second-line chemotherapy in neuroendocrine carcinomas. A case series and review of the literature”, Eur J Oncol Env Hea, vol. 21, no. 2, pp. 123–129, Jul. 2016, Accessed: Nov. 14, 2025. [Online]. Available: https://mail.mattioli1885journals.com/index.php/EJOEH/article/view/4362